E-viri
PDF
Recenzirano
Odprti dostop
-
Konkle, Barbara A; Shapiro, Amy D; Quon, Doris V; Staber, Janice M; Kulkarni, Roshni; Ragni, Margaret V; Chhabra, Ekta S; Poloskey, Stacey; Rice, Kara; Katragadda, Suresh; Fruebis, Joachim; Benson, Craig C
New England journal of medicine/The New England journal of medicine, 09/2020, Letnik: 383, Številka: 11Journal Article
In a study involving patients with severe hemophilia A, an injection of the novel fusion protein BIVV001 resulted in a duration of factor VIII activity that was up to four times as long as that for recombinant factor VIII, an increase that may signal the possibility of weekly therapy.
